[Status of cholesterol goal attainment for the primary and secondary prevention of atherosclerotic cardiovascular disease in dyslipidemia patients receiving lipid-lowering therapy: DYSIS-China subgroup analysis].

血脂异常 医学 内科学 胆固醇 子群分析 二级预防 疾病 置信区间
作者
Y Li,Shaoping Zhao,P Ye,Xuhe Yan,Yu Mu,Yao Wei,Dekai Hu,DYSIS-China Study Investigators
出处
期刊:PubMed 卷期号:44 (8): 665-70 被引量:6
标识
DOI:10.3760/cma.j.issn.0253-3758.2016.08.006
摘要

To analyze the current status of cholesterol goal attainment for the primary and secondary prevention of cardiovascular disease in dyslipidemia patients using data from the DYSIS-China study.Based on criteria defined in the 2014 China Cholesterol Education Program (CCEP) and the 2007 Chinese guidelines for the prevention and treatment of dyslipidemia in adults, 25 317 dyslipidemia patients enrolled in the DYSIS-China study (from March 2012 to October 2012) were stratified to the atherosclerotic cardiovascular disease(ASCVD) primary prevention and secondary prevention groups. The total cholesterol (TC) target goals were <3.11, 4.14, 5.18, and 6.22 mmol/L, respectively, and the low-density lipoprotein cholesterol (LDL-C) therapeutic goals were less than 1.8, 2.6, 3.4, and 4.1 mmol/L, respectively, for the very high-risk, high-risk, moderate-risk, and low-risk patients in the primary prevention group. The TC targets for the very high-risk and high-risk patients were <3.11 and <4.14 mmol/L, respectively, and the LDL-C targets were <1.8 and <2.6 mmol/L, respectively, in the secondary prevention group. The TC and LDL-C goal attainment rates were calculated for the different risk groups according to the targets values.Totally, 71.09% (n=18 000) of the dyslipidemia patients were grouped into very high and high risk groups, 51.76% (n=13 104) and 48.24% (n=12 213) patients were stratified to primary and secondary prevention of ASCVD. The LDL-C and TC goal attainment rates for the secondary prevention group were 33.09%(4 041 cases) and 21.05% (2 571 cases), respectively. The LDL-C and TC goal attainment rates for the primary prevention group were 52.40% (6 866 cases) and 42.06% (5 511 cases), respectively. Multivariate logistic regression analysis showed that diabetes mellitus(OR=5.75, 4.15, P<0.05), coronary heart disease(OR=5.70, 3.58, P<0.001), and peripheral arterial disease(OR=2.42, 1.49, P<0.05) were risk factors for failure to achieve TC and LDL-C goals, respectively.Despite the widespread application of the 2014 CCEP and 2007 Chinese dyslipidemia guidelines, LDL-C goal attainment among secondary and primary prevention patients remains suboptimal in China. More rigorous guideline adherence is therefore required to increase the LDL-C and TC goal attainment rates and improve the long-term cardiovascular outcomes in Chinese dyslipidemia patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
蔺不平发布了新的文献求助10
刚刚
小刘发布了新的文献求助10
1秒前
宋星慧遥完成签到 ,获得积分10
1秒前
加菲丰丰举报求助违规成功
1秒前
hucchongzi举报求助违规成功
1秒前
kingwill举报求助违规成功
1秒前
1秒前
2秒前
shenzhou9发布了新的文献求助10
2秒前
2秒前
3秒前
LY发布了新的文献求助10
3秒前
上官若男应助kun采纳,获得10
4秒前
5秒前
思源应助文艺的千亦采纳,获得10
5秒前
量子星尘发布了新的文献求助10
5秒前
5秒前
5秒前
hucchongzi应助勤劳的鸡采纳,获得10
6秒前
江江江11完成签到,获得积分20
6秒前
7秒前
7秒前
8秒前
哟哟哟完成签到 ,获得积分10
8秒前
lzr完成签到,获得积分10
8秒前
xu完成签到,获得积分10
9秒前
Zoe应助wxj采纳,获得20
9秒前
蔺不平完成签到,获得积分10
11秒前
子系郎完成签到,获得积分10
11秒前
深情安青应助178181采纳,获得10
11秒前
华仔应助lamy采纳,获得10
11秒前
SYLH应助libiqing77采纳,获得200
11秒前
12秒前
12秒前
12秒前
13秒前
abala完成签到,获得积分10
13秒前
14秒前
SYLH应助JOY采纳,获得20
15秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 1000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 310
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3979392
求助须知:如何正确求助?哪些是违规求助? 3523308
关于积分的说明 11217159
捐赠科研通 3260797
什么是DOI,文献DOI怎么找? 1800211
邀请新用户注册赠送积分活动 878960
科研通“疑难数据库(出版商)”最低求助积分说明 807113